PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.12%
Revenue growth under 50% of MCHP's 10.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
223.36%
Gross profit growth above 1.5x MCHP's 15.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
31.15%
EBIT growth below 50% of MCHP's 140.04%. Michael Burry would suspect deeper competitive or cost structure issues.
31.15%
Operating income growth under 50% of MCHP's 132.00%. Michael Burry would be concerned about deeper cost or sales issues.
24.78%
Net income growth under 50% of MCHP's 87.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
37.80%
EPS growth at 50-75% of MCHP's 70.34%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
37.80%
Diluted EPS growth at 50-75% of MCHP's 70.34%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
14.90%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
14.90%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-75.13%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
35000.00%
OCF growth above 1.5x MCHP's 33.85%. David Dodd would confirm a clear edge in underlying cash generation.
321.90%
FCF growth above 1.5x MCHP's 34.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
28.18%
10Y revenue/share CAGR at 50-75% of MCHP's 51.09%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
17.88%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-2.29%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-82.91%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-387.17%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-184.17%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
21.11%
Below 50% of MCHP's 145.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.73%
Below 50% of MCHP's 14.52%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
7.09%
Below 50% of MCHP's 17.81%. Michael Burry suspects a serious short-term disadvantage in building book value.
-15.75%
Cut dividends over 10 years while MCHP stands at 180.63%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-15.75%
Negative 5Y dividend/share CAGR while MCHP stands at 175.02%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
56.02%
3Y dividend/share CAGR at 50-75% of MCHP's 81.65%. Martin Whitman might see a weaker short-term approach to distributing cash.
-12.39%
Firm’s AR is declining while MCHP shows 10.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.12%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.55%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-20.60%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.73%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.90%
SG&A declining or stable vs. MCHP's 4.80%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.